Disease Areas:
Cough,Idiopathic pulmonary fibrosisDevice Types:
This book chapter outlined optimal endpoints in clinical trials in patients with IPF. Commonly used endpoints included FVC, 6MWT, hospitalization, acute exacerbations, and mortality. Potential endpoints included patient-reported outcomes, cough, HRCT, biomarkers, and composite outcome measures.
